Abstract
On the model of Ehrlich carcinoma transplanted in mice it is shown that following the removal of the primary tumor the organism of operated mice produces factors enhancing the rate of relapses and metastasis. The tumor cells are shown to fix on their surface immunoglobulins capable of enhancing tumor development in the mice. The serum-derived tumor-enhancing immunoglobulins undergo active pinocytosis by the tumor cells. The fall in the level of these immunoglobulins is accompanied by a reduction of the rate of tumor growth.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
F. V. Donenko, S. M. Sitdikova, A. O. Kabieva, and L. V. Moroz,Byull. Eksp. Biol. Med.,114, No 12, 652–654 (1992).
F. V. Donenko, A. O. Kabieva, and L. V. Moroz,,114, No 11, 518–519 (1992).
F. V. Donenko, A. O. Kabieva, Yu. T. Volkov, and L. V. Moroz,,113, No 6, 642–645 (1992).
L. A. Osterman,Study of Biological Macromolecules Using Electrofocusing, Immunoelectrophoresis, and Radioisotope Methods [in Russian], Moscow (1983).
Z. P. Sofiinaet al. (eds.),Experimental Evaluation of Antitumor Drugs in the USSR and USA [in Russian], Moscow (1980).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 119, No 1, pp. 62–64, January, 1995
Rights and permissions
About this article
Cite this article
Donenko, F.V., Moroz, L.V. Immunoglobulins of the tumor-bearing host as potential regulators of the tumor recurrence rate and metastasis development: a study on the model of ehrlich carcinoma. Bull Exp Biol Med 119, 56–58 (1995). https://doi.org/10.1007/BF02445931
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02445931